Patent applications and USPTO patent grants for Solace Therapeutics, Inc..The latest application filed is for "methods and systems for performing a medical procedure".
Patent | Date |
---|---|
Pressure attenuation device Grant 11,197,981 - Connors , et al. December 14, 2 | 2021-12-14 |
Methods And Systems For Performing A Medical Procedure App 20210128197 - Connors; Kevin G. ;   et al. | 2021-05-06 |
Pressure Attenuation Device App 20200324091 - Connors; Kevin G. ;   et al. | 2020-10-15 |
Methods and systems for performing a medical procedure Grant 10,799,268 - Connors , et al. October 13, 2 | 2020-10-13 |
Pressure Attenuation Device App 20200254226 - Kind Code | 2020-08-13 |
Methods And Systems For Performing A Medical Procedure App 20200253636 - Kind Code | 2020-08-13 |
Implant With High Vapor Pressure Medium App 20200163543 - Schutt; Ernest George ;   et al. | 2020-05-28 |
Method Of Removing An Inflated Implant From A Bladder App 20200146799 - Connors; Kevin G. ;   et al. | 2020-05-14 |
Methods And Systems For Performing A Medical Procedure App 20200138556 - Cahill; Ryan J. ;   et al. | 2020-05-07 |
Removal Device App 20200121342 - Sullivan, III; Roy H. ;   et al. | 2020-04-23 |
Methods and systems for performing a medical procedure Grant 10,543,071 - Cahill , et al. Ja | 2020-01-28 |
Methods and systems for performing a medical procedure Grant 10,531,894 - Connors , et al. Ja | 2020-01-14 |
Implant with high vapor pressure medium Grant 10,383,510 - Schutt , et al. A | 2019-08-20 |
Treatment of patients with a compressible attenuation device Grant 7,074,178 - Connors , et al. July 11, 2 | 2006-07-11 |
Implantable self-inflating attenuation device Grant 6,988,983 - Connors , et al. January 24, 2 | 2006-01-24 |
High vapor pressure attenuation device Grant 6,976,951 - Connors , et al. December 20, 2 | 2005-12-20 |
Implantable valved pressure attenuation device Grant 6,976,950 - Connors , et al. December 20, 2 | 2005-12-20 |
Devices and methods for attenuation of pressure waves in the body Grant 6,682,473 - Matsuura , et al. January 27, 2 | 2004-01-27 |
SEC | 0001371796 | Solace Therapeutics Inc of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.